Within the next two weeks the expected certiorari petition may be filed in the captioned case.  The petition will challenge the Federal Circuit denial of patent-eligibility under 35 USC § 101 on claims to a pioneer method of fetal testing through a simple blood test without amniocentesis.

The Bilski Losing Streak:  If certiorari is granted, this case may represent a best chance to reverse the patent-eligibility losing streak that started in 2010 with Bilski. 

“The Sequenom Certiorari Petition: Whither Patent-Eligibility?”: The captioned paper (attached) provides an analysis of what may be the best way to challenge the Federal Circuit decision.